MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.65
+0.12 (1.14%)
Apr 1, 2026, 12:31 PM EDT - Market open
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $49.99 million as of April 1, 2026. Its market cap has increased by 48.06% in one year.
Market Cap
49.99M
Enterprise Value
40.87M
1-Year Change
48.06%
Ranking
Category
Stock Price
$10.65
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $49.99M, a decrease of -87.06%. That is a compound annual growth rate of -36.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 49.43M | -5.56% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 53.85M |
| Mereo BioPharma Group | 52.67M |
| Entera Bio | 51.75M |
| Radiopharm Theranostics | 51.08M |
| Metagenomi Therapeutics | 50.41M |
| OS Therapies | 49.65M |
| Xilio Therapeutics | 48.63M |
| Immutep | 47.54M |